AU vs FNV

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite robust profitability metrics—ROE of 38.71%, operating margin of 42.49%, and strong YoY earnings growth of 147.2%—the stock trades at a premium valuation with a P/E of 22.56 and Price/Book of 6.98, above sector averages. Persistent earnings misses over the last four quarters and a weak technical trend score of 10/100 suggest caution, even as analyst consensus remains at 'buy'. The current price of $106.26 sits above the Graham Number of $40.18, reflecting high growth expectations rather than defensive value.

Franco-Nevada exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a massive current ratio of 8.30, indicating a fortress balance sheet. While the stock trades at a significant premium to its Graham Number ($71.7) and Intrinsic Value ($170.21), this is supported by explosive YoY revenue growth of 85.8% and earnings growth of 108.8%. The company's royalty-based model is reflected in its extraordinary profit margins (61.64%), though current technical trends are bearish. Long-term value is driven by consistent earnings beats and a strong analyst target of $306.36. Price trades at a 28.6% premium to fair value estimate ($188.50), limiting near-term upside from a valuation perspective.